Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12840235rdf:typepubmed:Citationlld:pubmed
pubmed-article:12840235lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0036980lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0520886lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C1948041lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0288672lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0522523lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0231242lld:lifeskim
pubmed-article:12840235lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:12840235pubmed:issue7lld:pubmed
pubmed-article:12840235pubmed:dateCreated2003-7-3lld:pubmed
pubmed-article:12840235pubmed:abstractTextPatients with acute myocardial infarction complicated by cardiogenic shock have a high mortality despite the use of early reperfusion therapies with thrombolysis or percutaneous coronary intervention (PCI). Therefore, there is still need to evaluate therapy strategies in these patients.lld:pubmed
pubmed-article:12840235pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12840235pubmed:languageenglld:pubmed
pubmed-article:12840235pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12840235pubmed:citationSubsetIMlld:pubmed
pubmed-article:12840235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12840235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12840235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12840235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12840235pubmed:statusMEDLINElld:pubmed
pubmed-article:12840235pubmed:monthJullld:pubmed
pubmed-article:12840235pubmed:issn1042-3931lld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:ZeymerUweUlld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:WeberMichaelMlld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:NeuhausKarl-L...lld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:TebbeUlrichUlld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:VohringerHans...lld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:JakschRainerRlld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:BischoffKarl-...lld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:ToepelWolfgan...lld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:MarsalekParva...lld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:HornStefanSlld:pubmed
pubmed-article:12840235pubmed:authorpubmed-author:ALKK Study...lld:pubmed
pubmed-article:12840235pubmed:issnTypePrintlld:pubmed
pubmed-article:12840235pubmed:volume15lld:pubmed
pubmed-article:12840235pubmed:ownerNLMlld:pubmed
pubmed-article:12840235pubmed:authorsCompleteYlld:pubmed
pubmed-article:12840235pubmed:pagination385-9lld:pubmed
pubmed-article:12840235pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:meshHeadingpubmed-meshheading:12840235...lld:pubmed
pubmed-article:12840235pubmed:year2003lld:pubmed
pubmed-article:12840235pubmed:articleTitleProspective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.lld:pubmed
pubmed-article:12840235pubmed:affiliationMedizinische Klinik II, Klinikum Kassel, Germany. Uwe.Zeymer@t-online.delld:pubmed
pubmed-article:12840235pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12840235pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12840235pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12840235pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12840235lld:pubmed